Open AccessDesign of the VIALE-M phase III trial of venetoclax and oral azacitidine maintenance therapy in acute myeloid leukemia
Author(s) -
В. В. Иванов,
SuPeng Yeh,
Jiřı́ Mayer,
Lalit Saini,
Ali Ünal,
Michael Boyiadzis,
David Hoffman,
Kingston Kang,
Sadiya N. Addo,
Wellington Mendes,
Amir T. Fathi
Publication year - 2022
Publication title -
future oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.857
H-Index - 72
eISSN - 1744-8301
pISSN - 1479-6694
DOI - 10.2217/fon-2022-0450
Subject(s) - venetoclax , medicine , azacitidine , myeloid leukemia , oncology , maintenance therapy , minimal residual disease , leukemia , chemotherapy , chronic lymphocytic leukemia , biochemistry , gene expression , chemistry , dna methylation , gene